Artificial intelligence (AI) in Diagnostics Market Size Worth $11.18 Billion By 2034 | CAGR: 21.4%
The global artificial intelligence (AI) in diagnostics market size is expected to reach USD 11.18 Billion by 2034 according to a new study by Polaris Market Research. The report “Artificial intelligence (AI) In Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Hardware, Services); By Diagnosis (Cardiology, Oncology, Pathology, Radiology, Chest and Lung, Neurology, Others); By Region, Segment Forecast, 2026 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The market is emerging as a boon in the healthcare sector owing to the growing adoption of AI technology to assist medical professionals due to the increased rate of chronic diseases and overcome the challenge of physicians' shortfall in recent years. AI in disease diagnosis has the immense potential to detect diseases prior to their occurrence helps diagnosticians prepare for preventive measures and avoid emergencies.
Artificial intelligence (AI) in medical testing offers a greater value advantage of detecting multiple diseases with single image recognition than traditional technologies of specific disease detection and speed up the tests and reporting processes.
Questions? Request a sample or make an inquiry before buying this report by clicking the link below: Artificial Intelligence (AI) in Diagnostics Market Report
Artificial Intelligence (AI) in Diagnostics Market Highlight
-
The software segment accounted for largest AI diagnostics market share of 46.3% in 2025 driven due to the increasing adoption of AI based tools in hospitals, laboratories, and diagnostic centers
-
The oncology segment dominated the artificial intelligence in diagnostics market size with 32.8% in 2025 due to the increasing number of cancer cases and the increasing requirement for early detection
-
The North America market accounted for largest share of 53.89% in 2025 driven by early adoption of high-end healthcare technologies and presence of AI solutions providers
-
Europe is anticipated to witness growth of CAGR 20.6% during the forecast period. The region is witnessing increased investment in healthcare technology
-
The Asia Pacific region is expected to witness growth of CAGR 24.3% during the forecast period driven by increased healthcare expenditure, increased patient population and increased demand for high-end diagnostic services
-
Among the recent strategic initiative industry participants such as GE Healthcare, Lunit, Siemens Healthcare, Geisinger, Aidoc, Telemedicine Clinic (TMC), AliveCor, Medable, Inc., Zebra Medical Vision, and Nuance are some of the key players who emphasized creating an advanced vision of utilizing global industry.
Artificial Intelligence (AI) in Diagnostics Market report on the basis of component, diagnosis, and region:
Artificial intelligence (AI) in Diagnostics, Component Outlook (Revenue –USD Billion, 2021 - 2034)
-
Software
-
Hardware
-
Services
Artificial intelligence (AI) in Diagnostics, Diagnosis Outlook (Revenue - USD Billion, 2021 - 2034)
-
Cardiology
-
Oncology
-
Pathology
-
Radiology
-
Chest and Lung
-
Neurology
-
Others
Artificial intelligence (AI) in Diagnostics, Regional Outlook (Revenue - USD Billion, 2021 - 2034)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
Germany
-
UK
-
Italy
-
France
-
Spain
-
Austria
-
Netherlands
-
-
Asia Pacific
-
China
-
Japan
-
India
-
Indonesia
-
Malaysia
-
South Korea
-
-
Latin America
-
Brazil
-
Argentina
-
Mexico
-
-
Middle East & Africa
-
Israel
-
Saudi Arabia
-
South Africa
-
UAE
-